Develops innovative drugs addressing PREgnancy issues
ObsEva has raised €80M across 2 funding rounds from 5 investors, most recently a Series B round in Nov 2015. Based in Plan-les-Ouates, Switzerland; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2015-11-01 | Series B | €54M | HBM Partners,New Enterprise Associates,Novo Ventures,OrbiMed,Sofinnova Partners | View deal → |
| 2013-08-01 | Series A | €26M | Novo Ventures,Sofinnova Partners | View deal → |
